NCT03790839View on ClinicalTrials.gov

Drug Interaction Study Between Dorzagliatin and Sitagliptin

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2019

Primary Completion Date

August 30, 2019

Study Completion Date

August 30, 2019

Conditions
Patients
Interventions
DRUG

Sitagliptin

Sitagliptin (Januvia® 100 mg tablets for oral administration)

DRUG

Dorzagliatin

Glucokinase activator currently under development

Trial Locations (1)

07601

Frontage Clinical Services Inc., Hackensack

Sponsors
All Listed Sponsors
lead

Hua Medicine Limited

INDUSTRY

NCT03790839 - Drug Interaction Study Between Dorzagliatin and Sitagliptin | Biotech Hunter | Biotech Hunter